AI in drug Discovery 9 March - 10 March 2026 PFS & Injectable Drug Devices East Coast 27 April - 29 April 2026 PFS & Injectable Drug Devices West Coast 8 June - 10 June 2026 PFS & Injectable Drug Devices Europe 12 January - 14 January 2027

Pluristem Therapeutics Inc., a regenerative medicine company developing novel placenta-based cell therapy products, has announced a collaboration between the company and NASA’s Ames Research Center to evaluate the potential of the company's PLX cell therapies in...

NAMSA has launched an in vitro diagnostic (IVD) development business to provide global manufacturers a proven resource for expedited commercialization outcomes delivered via NAMSA’s “Uniquely IVD” regulatory, quality, and clinical research...

Researchers and physicians at Johns Hopkins University, Baltimore, MD, will collaborate with the nanoelectronics R&D center Imec, Leuven, Belgium, to advance silicon applications in healthcare, beginning with development of a device to enable a broad range of clinical tests. The...

Indiana Governor Mike Pence joined state-based global life sciences and research university executives to unveil the Indiana Biosciences Research Institute, the first industry-led collaborative life sciences research institute in the country. The Indiana Biosciences Research Institute is...

BHA and BHT are well-known food preservatives that are excellent radical scavengers. These compounds, attached to single-walled carbon nanotubes (SWNTs), could serve as excellent radical traps. The amino-BHT groups can be associated with SWNTs that have carbolyxic acid groups via acid-base...

It's illegal for health products with medical formulations to be accepted by the U.S. Food and Drug Administration without tests on animals - a situation that has serious ethical and moral implications. New research in the field of tissue engineering, by Professor Amit Gefen of Tel Aviv University's Faculty of...